Roquefort Therapeutics plc

LSE:ROQ.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

💊 Pharmaceuticals

💰 Venture Capital

Location

United Kingdom

Market Cap

USD 2.96 M

Share Price

USD 0.02

Avg Daily Volume

1,109,212

Change (1 day)

-9.72%

Change (1 year)

-69.15%

Change (YTD)

-62.96%

Roquefort Therapeutics plc Interest Coverage Ratio for the year ending December 31, 2023: -33,314.40

Roquefort Therapeutics plc Interest Coverage Ratio is -33,314.40 for the year ending December 31, 2023. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Competitors

Samsung Biologics Co.,Ltd.

USD 751.47

207940.KS

-12.51 -1.64%

Royalty Pharma plc

USD 35.59

RPRX

+0.12 0.34%

AbbVie Inc.

USD 189.26

ABBV

-2.14 -1.12%

Novo Nordisk A/S

USD 64.39

NOVO-B.CO

-1.34 -2.03%

Roche Holding AG

USD 340.88

RO.SW

+2.44 0.72%

Novartis AG

USD 115.07

NOVN.SW

-0.81 -0.70%

AstraZeneca PLC

USD 138.02

AZN.L

-0.31 -0.22%

Abbott Laboratories

USD 123.67

ABT

+3.16 2.62%

Merck & Co., Inc.

USD 79.96

MRK

-1.56 -1.91%

Thermo Fisher Scientific Inc.

USD 414.75

TMO

-10.23 -2.41%

Amgen Inc.

USD 294.76

AMGN

-3.49 -1.17%

Boston Scientific Corporation

USD 103.64

BSX

-1.01 -0.97%

Pfizer Inc.

USD 24.47

PFE

-0.11 -0.45%

Gilead Sciences, Inc.

USD 108.22

GILD

-0.58 -0.53%

Vertex Pharmaceuticals Incorporated

USD 459.81

VRTX

-3.46 -0.75%

Sanofi

USD 96.63

SAN.PA

-0.24 -0.24%

Bristol-Myers Squibb Company

USD 47.36

BMY

-0.70 -1.46%

CSL Limited

USD 167.39

CSL.AX

+6.23 3.87%

Chugai Pharmaceutical Co., Ltd.

USD 47.05

4519.T

+0.49 1.05%

GSK plc

USD 18.07

GSK.L

-0.88 -4.65%

Key Data

Date	Interest Coverage Ratio	Return on Capital Employed (ROCE)	Return on Equity (ROE)	Return on Assets (ROA)